GENE THERAPY FOR RETINITIS PIGMENTOSA Read more about GENE THERAPY FOR RETINITIS PIGMENTOSA European Patent20199208.8Filed on 2015-07-17
USING MACHINE LEARNING AND/OR NEURAL NETWORKS TO VALIDATE STEM CELLS AND THEIR DERIVATIVES FOR USE IN CELL THERAPY, DRUG DISCOVERY, AND DIAGNOSTICS Read more about USING MACHINE LEARNING AND/OR NEURAL NETWORKS TO VALIDATE STEM CELLS AND THEIR DERIVATIVES FOR USE IN CELL THERAPY, DRUG DISCOVERY, AND DIAGNOSTICS Japan2020-549687Filed on 2019-03-15
USING MACHINE LEARNING AND/OR NEURAL NETWORKS TO VALIDATE STEM CELLS AND THEIR DERIVATIVES FOR USE IN CELL THERAPY, DRUG DISCOVERY, AND DIAGNOSTICS Read more about USING MACHINE LEARNING AND/OR NEURAL NETWORKS TO VALIDATE STEM CELLS AND THEIR DERIVATIVES FOR USE IN CELL THERAPY, DRUG DISCOVERY, AND DIAGNOSTICS European Patent19714930.5Filed on 2019-03-15
USING MACHINE LEARNING AND/OR NEURAL NETWORKS TO VALIDATE STEM CELLS AND THEIR DERIVATIVES FOR USE IN CELL THERAPY, DRUG DISCOVERY, AND DIAGNOSTICS Read more about USING MACHINE LEARNING AND/OR NEURAL NETWORKS TO VALIDATE STEM CELLS AND THEIR DERIVATIVES FOR USE IN CELL THERAPY, DRUG DISCOVERY, AND DIAGNOSTICS Canada3094078Filed on 2019-03-15
USING MACHINE LEARNING AND/OR NEURAL NETWORKS TO VALIDATE STEM CELLS AND THEIR DERIVATIVES FOR USE IN CELL THERAPY, DRUG DISCOVERY, AND DIAGNOSTICS Read more about USING MACHINE LEARNING AND/OR NEURAL NETWORKS TO VALIDATE STEM CELLS AND THEIR DERIVATIVES FOR USE IN CELL THERAPY, DRUG DISCOVERY, AND DIAGNOSTICS Australia2019236297Filed on 2020-09-16
Using Machine Learning And/or Neural Networks To Validate Stem Cells And Their Derivatives (2-D Cells And 3-D Tissues) For Use In Cell Therapy And Tissue Engineered Products Read more about Using Machine Learning And/or Neural Networks To Validate Stem Cells And Their Derivatives (2-D Cells And 3-D Tissues) For Use In Cell Therapy And Tissue Engineered Products US Patent 11,531,844Filed on 2020-09-16
Druggable Taraget to Treat Retinal Degeneration Read more about Druggable Taraget to Treat Retinal Degeneration Patent Cooperation TreatyPCT/US2020/050540Filed on 2020-09-11
METHOD FOR REPRODUCIBLE DIFFERENTIATION OF CLINICAL-GRADE RETINAL PIGMENT EPITHELIUM CELLS Read more about METHOD FOR REPRODUCIBLE DIFFERENTIATION OF CLINICAL-GRADE RETINAL PIGMENT EPITHELIUM CELLS US Patent 12,065,671Filed on 2020-07-16
RP2 and RPGR Vectors for Treating X-Linked Retinitis Pigmentosa Read more about RP2 and RPGR Vectors for Treating X-Linked Retinitis Pigmentosa Japan2020-167984Filed on 2020-10-02
USE OF IL-34 TO TREAT RETINAL INFLAMMATION AND NEURODEGENERATION Read more about USE OF IL-34 TO TREAT RETINAL INFLAMMATION AND NEURODEGENERATION US Application 16/971,288Filed on 2020-08-19